These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2883700)

  • 21. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety.
    Calleo J; Williams JR; Amspoker AB; Swearingen L; Hirsch ES; Anderson K; Goldstein SR; Grill S; Lehmann S; Little JT; Margolis RL; Palanci J; Pontone GM; Weiss H; Rabins P; Marsh L
    J Parkinsons Dis; 2013; 3(4):603-8. PubMed ID: 24275604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White matter lesions and depression in patients with Parkinson's disease.
    Petrovic IN; Stefanova E; Kozic D; Semnic R; Markovic V; Daragasevic NT; Kostic VS
    J Neurol Sci; 2012 Nov; 322(1-2):132-6. PubMed ID: 22857990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for atypical depression in Parkinson's disease.
    Schiffer RB; Kurlan R; Rubin A; Boer S
    Am J Psychiatry; 1988 Aug; 145(8):1020-2. PubMed ID: 3394854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The concept of bradyphrenia.
    Lees AJ
    Rev Neurol (Paris); 1994 Dec; 150(12):823-6. PubMed ID: 7676117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder.
    Beucke JC; Uhl I; Plotkin M; Winter C; Assion HJ; Endrass T; Amthauer H; Kupsch A; Juckel G
    World J Biol Psychiatry; 2010 Sep; 11(6):781-7. PubMed ID: 20586535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Depression in Parkinson's disease].
    Yamamoto M
    Nihon Rinsho; 2004 Sep; 62(9):1661-6. PubMed ID: 15462381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bupropion in the treatment of depression in Parkinson's disease.
    Załuska M; Dyduch A
    Int Psychogeriatr; 2011 Mar; 23(2):325-7. PubMed ID: 20809995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parkinson syndrome and depression].
    Bader JP; Hell D
    Fortschr Neurol Psychiatr; 1998 Jul; 66(7):303-12. PubMed ID: 9697005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of the prevalence and etiology of depression in Parkinson's disease.
    Habermann-Little B
    J Neurosci Nurs; 1991 Jun; 23(3):165-9. PubMed ID: 1831481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depressive symptoms in Parkinson's disease are related to decreased left hippocampal volume: correlation with the 15-item shortened version of the Geriatric Depression Scale.
    Goto M; Kamagata K; Hatano T; Hattori N; Abe O; Aoki S; Hori M; Gomi T
    Acta Radiol; 2018 Mar; 59(3):341-345. PubMed ID: 28691530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
    Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background.
    Yamamoto M
    J Neurol; 2001 Sep; 248 Suppl 3():III5-11. PubMed ID: 11697689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parkinson disease and depression: a research carried out with the neurology service at S. Joao Hospital].
    Lume J
    Acta Med Port; 1990; 3(2):95-100. PubMed ID: 2349895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and Parkinson's disease.
    Mayeux R; Williams JB; Stern Y; Côté L
    Adv Neurol; 1984; 40():241-50. PubMed ID: 6695601
    [No Abstract]   [Full Text] [Related]  

  • 36. [Depressive disorders in Parkinson's disease: clinical presentations, diagnosis, treatment].
    Maruta NA; Saiko DY; Denisenko MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11 Pt 2):42-7. PubMed ID: 24429964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pain in depression and Parkinson's disease.
    King SA
    Am J Psychiatry; 1993 Feb; 150(2):353-4. PubMed ID: 8422101
    [No Abstract]   [Full Text] [Related]  

  • 38. Depression, psychosis and dementia in Parkinson's disease.
    Baker MG
    Neurology; 1999; 52(7 Suppl 3):S1. PubMed ID: 10227601
    [No Abstract]   [Full Text] [Related]  

  • 39. The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment.
    Imamura K; Okayasu N; Nagatsu T
    Acta Neurol Scand; 2011 Jul; 124(1):28-39. PubMed ID: 20880269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression as a cause of hallucinations in Parkinson's disease.
    Sandyk R; Gillman MA
    Clin Neuropharmacol; 1985; 8(2):199-200. PubMed ID: 4005870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.